Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Oct 13, 2014
5 / 5 (8) | 2
An experimental treatment that trains a patient's immune system to attack their cancer caused remission in 90 per cent of leukaemia patients on a small-scale trial, though experts warn questions remain.
Oct 17, 2014
4.5 / 5 (4) | 0